Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood
Eva Morales1, Jordi Julvez, Maties Torrent
1From the aCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Catalonia, Spain; bVirgen de la Arrixaca Universtiy Hospital, IMIB-Arrixaca Research Institute, Murcia, Spain; cCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; dHospital del Mar Medical Research Institute (IMIM), Barcelona, Catalonia, Spain; eUniversitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain; fIB-SALUT, Area de Salut de Menorca, Balearic Islands, Spain; gUniversity of Valencia, Valencia, Spain; hCenter for Public Health Research (CSISP-FISABIO), Valencia, Spain; iDepartment of Basic Psychological Processes and Their Development, Basque Country University UPV/EHU, San Sebastian, Spain; jBiodonostia Institute, San Sebastian, Gipuzkoa, Spain; kPublic Health Laboratory, Basque Government, Bilbao, Spain; lHospital San Agustín, Avilés, Asturias, Spain; and mUniversity of Oviedo, Asturias, Spain.
Insights
Maternal vitamin D levels during pregnancy may reduce the risk of attention deficit and hyperactivity disorder (ADHD) symptoms in children. Higher vitamin D (25(OH)D3) concentrations were linked to fewer ADHD-like symptoms and a lower risk of diagnosis.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Nutritional Epidemiology
Background:
- Prenatal vitamin D status is hypothesized to impact childhood attention deficit and hyperactivity disorder (ADHD) risk.
- Prospective studies investigating this link are lacking.
- This study examined the association between maternal vitamin D levels during pregnancy and ADHD-like symptoms in offspring.
Purpose of the Study:
- To investigate the prospective association between maternal vitamin D status in pregnancy and the risk of ADHD-like symptoms in children.
- To determine if higher concentrations of 25-hydroxyvitamin D3 [25(OH)D3] during gestation correlate with reduced ADHD symptomology.
Main Methods:
- A prospective study of 1,650 mother-child pairs from the INMA Project (Spain).
- Maternal plasma 25(OH)D3 was measured at 13 weeks gestation.
- Children's ADHD-like symptoms were assessed by teachers at ages 4-5 years using DSM ADHD criteria.
Main Results:
- An 11% decrease in total ADHD-like symptoms per 10 ng/ml increase in maternal 25(OH)D3 (IRR = 0.89; 95% CI = 0.80, 0.98).
- Significant reductions in inattention (IRR = 0.89; 95% CI = 0.79, 0.99) and hyperactivity-impulsivity (IRR = 0.88; 95% CI = 0.78, 0.99) symptoms.
- A trend towards lower risk for ADHD DSM-IV and ICD-10 hyperkinetic disorder with higher maternal 25(OH)D3.
Conclusions:
- Elevated maternal 25(OH)D3 levels during pregnancy are associated with a reduced risk of ADHD-like symptoms in offspring.
- This finding supports the importance of adequate vitamin D status during prenatal development.
- Further research may elucidate the mechanisms underlying this association.
Background:
Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated with risk of ADHD-like symptoms in offspring.
Methods:
We conducted a prospective study analyzing data from 1,650 mother-child pairs from five birth cohorts embedded in the INMA Project (Spain, 1997-2008). Maternal vitamin D status in pregnancy was estimated by measuring plasma concentration of 25-hydroxyvitamin D3 [25(OH)D3] at 13 weeks of gestation. Children were assessed by teachers for ADHD-like symptoms at ages 4-5 years using the Diagnostic and Statistical Manual of Mental Disorders ADHD form list.
Results:
After adjustment, the number of total ADHD-like symptoms in children decreased by 11% per 10 ng/ml increment of maternal 25(OH)D3 concentration (incidence rate ratio [IRR] = 0.89; 95% confidence interval [CI] = 0.80, 0.98). Similarly, the number of symptoms in the ADHD subscales decreased in relation to higher maternal 25(OH)D3 concentration (IRR per 10 ng/ml increment = 0.89; 95% CI = 0.79, 0.99 for the inattention scale; and IRR = 0.88; 95% CI = 0.78, 0.99 for the hyperactivity-impulsivity scale). Using diagnostic criteria, we found an association of increasing maternal 25(OH)D3 with a lower risk of ADHD DSM-IV (relative risk ratio per 10 ng/ml increment = 0.87; 95% CI = 0.72, 1.06) and ICD-10 hyperkinetic disorder (relative risk ratio = 0.72; 95% CI = 0.49, 1.04) in children.
Conclusion:
Higher maternal circulating levels of 25(OH)D3 in pregnancy are associated with lower risk of developing ADHD-like symptoms in childhood.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Vitamins
Oppositional Defiant Disorder
Diagnostic Criteria and...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Environmental Influences on Intelligence
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...